Skip to main content
. 2023 Feb 2;6(2):e2254221. doi: 10.1001/jamanetworkopen.2022.54221

Figure 1. Characteristics of Clonal Hematopoiesis (CH) and CH Alterations Annotated as Likely Putative Drivers (CH-PD) in Patients With Metastatic Esophagogastric Cancer (EGC) and Colorectal Cancer (CRC).

Figure 1.

In the CRC group (n = 301), CH and CH-PD were present in 83 (27.6%) and 44 (14.6%) patients, respectively. In the EGC group (n = 332), CH and CH-PD were present in 115 (34.6%) and 55 (16.6%) patients, respectively. The most frequently altered CH (A) and CH-PD (B) genes in the metastatic EGC and CRC groups (frequency, ≥0.01) and age at diagnosis for EGC and CRC groups based on CH (C) and CH-PD (D) status are shown.